TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 45 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $200,641 | +19.3% | 11,291 | +21.3% | 0.00% | – |
Q2 2023 | $168,159 | +16.6% | 9,306 | -18.9% | 0.00% | – |
Q1 2023 | $144,228 | +31.4% | 11,474 | +53.2% | 0.00% | – |
Q4 2022 | $109,789 | -12.9% | 7,489 | +1.7% | 0.00% | – |
Q3 2022 | $126,000 | +0.8% | 7,367 | -14.1% | 0.00% | – |
Q2 2022 | $125,000 | +58.2% | 8,572 | +81.4% | 0.00% | – |
Q1 2022 | $79,000 | -38.3% | 4,726 | -16.9% | 0.00% | – |
Q4 2021 | $128,000 | +10.3% | 5,687 | +5.0% | 0.00% | – |
Q3 2021 | $116,000 | -28.0% | 5,417 | -2.8% | 0.00% | – |
Q2 2021 | $161,000 | +26.8% | 5,574 | +41.6% | 0.00% | – |
Q1 2021 | $127,000 | -28.7% | 3,936 | -8.8% | 0.00% | – |
Q4 2020 | $178,000 | – | 4,314 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,417,157 | $41,069,000 | 3.79% |
Vivo Capital, LLC | 2,987,331 | $86,573,000 | 3.75% |
Cormorant Asset Management, LP | 1,514,269 | $43,884,000 | 1.49% |
Ghost Tree Capital, LLC | 170,000 | $4,927,000 | 1.35% |
RTW INVESTMENTS, LP | 2,013,601 | $58,354,000 | 0.88% |
COWEN AND COMPANY, LLC | 514,289 | $14,904,000 | 0.78% |
Perceptive Advisors | 2,592,832 | $75,140,000 | 0.49% |
Altium Capital Management LP | 70,573 | $2,045,000 | 0.47% |
TimesSquare Capital Management, LLC | 686,705 | $19,901,000 | 0.16% |
Jefferies Group LLC | 442,993 | $12,837,937 | 0.08% |